Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / February / FDA Greenlights Repeat Use of Glaukos iDose TR
Glaucoma Latest News

FDA Greenlights Repeat Use of Glaukos’ iDose® TR

Glaukos announces US FDA approval of NDA supplement allowing for re-administration of treatment

2/4/2026 1 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
Top Institutions in Ophthalmology

Leading institutions in ophthalmology and glaucoma research conduct clinical trials and translational research on novel drug delivery systems, sustained-release implants, and glaucoma surgical interventions, contributing to evidence on safety, efficacy, and long-term outcomes.

  • #1

    Bascom Palmer Eye Institute

    Miami, FL

    Bascom Palmer is consistently ranked as a top ophthalmology center with extensive glaucoma research programs and leadership in clinical trials evaluating novel glaucoma therapies and drug delivery systems.

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Clinical Trials
  • #2

    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Known for innovation in glaucoma treatment and drug delivery research, MEE conducts leading clinical trials and translational studies on sustained-release glaucoma therapies.

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Translational Research
  • #3

    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Wilmer Eye Institute has a robust glaucoma research program with expertise in sustained drug delivery and implantable devices, contributing to clinical evidence on safety and efficacy.

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Clinical Research
  • #4

    Duke Eye Center

    Durham, NC

    Duke Eye Center is recognized for its clinical research in glaucoma, including studies on novel sustained-release drug delivery implants and their long-term safety profiles.

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Clinical Trials

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: